Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls

Zheng Ye(University of Cambridge), John Danesh(University of Cambridge), Julian P. T. Higgins(University of Bristol), Rory Collins(University of Oxford), Gordon Lowe(University of Glasgow), Eugene H. C. Liu(National University of Singapore), Bernard Keavney(Manchester Academic Health Science Centre)

The Lancet

February 1, 2006

10.1016/s0140-6736(06)68263-9

Cited by 409

Related Papers

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

|The Lancet|2003|3.8k

Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

|The Lancet|2018|3.5k

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

|The Lancet|2005|2.9k

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

|The Lancet|2016|2.8k

Graphical Tools for Network Meta-Analysis in STATA

|PLoS ONE|2013|2.5k